First of its kind, Digital Therapeutics Summit at Dartmouth brings academic, government, and industry leaders to campus.
Post Tagged with: "CTBH"
Researchers from the Center for Technology and Behavioral Health (CTBH) at Dartmouth’s Geisel School of Medicine, Dartmouth-Hitchcock, and Pontificia Universidad Javeriana in Bogotá, Colombia, received an award from Colombia’s National Academy of Medicine for their work implementing a new primary care model for widespread access to diagnosis and treatment of depression and unhealthy alcohol use.
A research team at Dartmouth’s Geisel School of Medicine has been approved for a $5.3 million funding award from the Patient-Centered Outcomes Research Institute (PCORI)—to conduct comparative clinical effectiveness research on medication-assisted treatment for pregnant women with opioid use disorders.
In a briefing to the House Bipartisan Heroin Task Force, Geisel professor Lisa Marsch, PhD, Principal Investigator of the Northeast Node of the National Drug Abuse (NIDA) Clinical Trials Network, presented data from her NIDA-funded New Hampshire Hot Spot Study on heroin and synthetic drug use.
Lisa Marsch, PhD, a professor of psychiatry and director of the Dartmouth Center for Technology and Behavioral Health, has been appointed to the Andrew G. Wallace Professorship at the Geisel School of Medicine.
The National Institute on Drug Abuse (NIDA) has awarded a five-year $3.8 million grant to Dartmouth’s Center for Technology and Behavioral Health. The award will support the launch of the new Northeast Node in NIDA’s National Clinical Trials Network, and clinical trials conducted by the Node will be supported by additional research project grants from NIDA, part of the National Institutes of Health.